Skip to main content
Medicina logoLink to Medicina
. 2026 Jun 18;62(6):1186. doi: 10.3390/medicina62061186

A Bibliographic Review of Airborne Fungal Allergens from Dominant and Undercharacterized Genera

Noemi-Teofana Musta 1, Nicoleta Ianovici 1,*
Editor: Patrick Geraghty1
PMCID: PMC13302811  PMID: 42356198

Abstract

Atmospheric fungi represent an important group of allergens with a major impact on public health, especially among sensitized or immunocompromised individuals. This article reviews the ubiquitous fungal taxa in the atmosphere—Alternaria, Cladosporium, Aspergillus, Penicillium—as well as the undercharacterized taxa—Epicoccum, Pithomyces, Torula and Rhodotorula—with an emphasis on the antigenic composition and protein structures involved in type I hypersensitivity reactions. Recent data from the scientific literature (2000–2025) is presented, along with the frequency of spores in the atmosphere and the global distribution of research, highlighted by the analysis of Google Scholar and PubMed results. While Alternaria, Aspergillus, Penicillium, and Cladosporium are recognized as major contributors to allergic sensitization worldwide, Epicoccum, Torula, Rhodotorula, and Pithomyces remain relatively undercharacterized, but associated with allergic reactions and cross-reactivity.

Keywords: fungal allergy, fungal airborne allergens, IgE-mediated hypersensitivity, aerobiology

1. Ecological and Climatic Context

This review aims to analyze the literature published between 2000 and 2025, regarding both dominant and emerging fungal genera in the atmosphere—Alternaria, Penicillium, Aspergillus, Cladosporium, Epicoccum, Torula, Rhodotorula, Pithomyces. While Alternaria, Aspergillus, Penicillium, and Cladosporium are recognized as major contributors to allergic sensitization worldwide, Epicoccum, Torula, Rhodotorula, and Pithomyces remain relatively undercharacterized, but are associated with allergic reactions and cross-reactivity. To ensure a rigorous and up-to-date overview, a systematic search of the PubMed and Google Scholar databases was performed, using combinations of keywords related to the selected fungal genera.

In recent decades, the problems of climate and chemical changes followed by their effects on human health have been a subject of interest for both the general public and the scientific community. Bioaerosols can represent up to 10% of the total mass of suspended particles in the atmosphere [1]. Among these particles are fungal spores. The concentration of spores in the atmosphere depends on environmental factors (temperature, wind, humidity, precipitation), and the amplitude of the action on health depends on the air pollutants [2,3]. Epidemiological studies have shown that the Westernized lifestyle, urbanization and high levels of emissions resulting from the combustion of fossil fuels are correlated with an increased frequency of respiratory allergies, predominantly in the urban population compared to the rural one, likely due to the combined effects of air pollutants and airborne allergens in enhancing airway inflammation and allergic sensitization [4].

From a climatic point of view, the 21st century represents a peak of global warming. In addition to the increase in average temperature, extreme weather events such as cyclones, droughts and hurricanes, and the frequency of heat waves are on the rise. According to the World Health Organization, the predominantly negative effects of these changes are reflected in drinking water, stable food sources and air quality in both outdoor and indoor environments [5,6]. By favoring periods of drought and atmospheric dryness, global warming has led to significant changes in the spectrum of fungal taxa present in the atmosphere and in the biochemical transformations they undergo [7]. Smoke from wildfires can damage epithelial integrity, with subsequent effects on T helper lymphocytes [8]. Multiple cases of asthma attacks during thunderstorms have been documented due to the disintegration of pollen grains, resulting in the release of allergenic particles [9]. The study by Pulimood et al., 2007 [10] in the UK demonstrated that asthma patients sensitized to the release of aeroallergens during these storms were prone to develop respiratory allergies to Cladosporium and Alternaria spores.

Air pollutants can modify the allergenic potential of fungal spores by chemical modifications, increasing their allergenic potential and facilitating their entry into the respiratory tract. Direct action on the body, causing inflammation, oxidative stress and damage to the respiratory epithelium, can culminate in an allergic response [11]. Among the substances that have a significant impact on air quality are carbon dioxide, particulate matter, nitrogen dioxide, ozone and sulfur dioxide [12]. The number of fungal spores increases with the concentration of carbon dioxide in the atmosphere, which leads to an amplification of the presence and severity of respiratory allergies [7]. Through the action of nitrogen dioxide, ozone, sulfur dioxide and particulate matter, the epithelial barrier becomes more permeable, immune responses are modified and dysbiosis occurs [12,13,14,15]. The association between pollution and heat stress increases morbidity and mortality by inducing inflammation and lowering the threshold of allergic airway reactivity [16].

Environmental and climatic changes may also influence the distribution and prevalence of atmospheric fungal taxa, potentially modifying the patterns of both exposure and sensitization. While dominant genera are habituated to urban and polluted environments, changing ecological conditions may additionally favor the spread of lesser explored fungi. Variations in temperature, humidity and atmospheric carbon dioxide concentrations can influence sporulation and seasonal distribution, leading to changes in airborne spore load and exposure duration. In this context, prolonged exposure to mixed airborne fungal allergens may contribute not only to the amplification of inflammation, but also to the emergence of sensitization patterns that are currently insufficiently understood.

2. Relevant Immunological Aspects

Allergic reactions occur when a genetically susceptible individual interacts with a trigger factor, which has a broad spectrum of action, affecting people of different ages and multiple organs [17]. Trigger factors are antigens of different types and sizes, depending on how they are recognized by the immune system: low molecular weight proteins can associate with other serum proteins to form epitopes, and high molecular weight proteins can be recognized and processed directly by antibodies and T lymphocytes [18].

Fungi are eukaryotic, heterotrophic organisms, ubiquitous in nature, widespread in different habitats and with a dual role as symbionts and saprophytes [19,20]. The body of fungi is called mycelium and is made up of hyphae [21]. Reproduction occurs through spores, sexual or asexual, which can easily disperse in the atmosphere [22,23]. They are among the first structures identified as having hypersensitivity effects on the body. The incidence of allergies caused by fungi has increased in the last two decades [24,25].

Fungi produce proteins that, once they enter the body, cause the formation of specific IgE antibodies and, implicitly, sensitization. Subsequent exposure to the same antigens will lead to the appearance of an allergic reaction, generally manifested by allergic rhinitis and asthma [26]. Studies indicate a clear link between exposure to airborne fungal spores and hypersensitivity reactions of the body. The severity of the reactions produced in the body upon the penetration of proteins with an antigenic effect is increased: unlike other allergens, fungal spores can lead to the appearance of severe complications that endanger the lives of immunocompromised patients [27]. Next, fungal genera whose role in hypersensitivity has been proven will be presented.

2.1. Alternaria

Alternaria is a genus belonging to the class Dothideomycetes. The first identified species is Alternaria alternata, whose original name was A. tenuis, followed by Torula alternata [28]. It contains saprophytic and pathogenic species that live mainly in the atmosphere, but also on soil, in indoor environments or on plants. Most Alternaria species are involved in the decomposition of organic matter and can act as pathogens for humans, animals and plants. As a phytopathogen, it can lead to crop damage both before and after harvest. In humans and animals, the species A. alternata leads to toxicosis, due to the toxic metabolites it produces (perylene, dibenzopyrone) and to allergic reactions, mainly through the Alt a 1 protein [29,30].

The incidence of sensitization to A. alternata is high, making it difficult to estimate an exact percentage. Studies on the effects of sensitization on the body are numerous and diverse, indicating the importance of studying the genus. The GA(2)LEN study identified a prevalence of symptoms of 69% in European patients, and it is well known that allergic reactions caused by A. alternata frequently require medical care and can lead to asthma [31]. In the United States, a direct link between the presence of spores in homes and the onset or exacerbation of asthma symptoms has been demonstrated [32]. The study by Downs et al., 2001 [33] demonstrated that, in children sensitized with Alternaria, wheezing and airway reactivity were higher than in non-sensitized children. The action of the fungus on the innate immune system has as possible consequences increased cathelicidin levels and mucus hypersecretion [34]. Repeated administration of A. alternata to murine models infected with influenza virus has been shown to cause, in addition to nasal mucosal inflammation, unexpected increases in morbidity and mortality [35]. Another study also in murine models demonstrates the importance of the major allergen Alt a 1, which can induce airway inflammation and allergic asthma [36].

In order to decipher the clinical profile, it was necessary to identify the allergenic proteins from A. alternata, describe them and identify homologues in other species to explain the phenomenon of cross-reactivity. In total, 17 proteins with a potential allergenic role were characterized, of which 12 are considered to be of increased importance [29,37]. The main possible allergens, presented in Table 1, were retrieved from the database www.allergen.org [38]. The list of allergens includes proteins ubiquitous in the environment, conserved in the evolutionary process, with homologues within species of the genera Aspergillus, Penicillium, and Cladosporium [39]. The presence of homologs indicates a high degree of cross-reactivity [40], the consequence of which is clinically observable by the occurrence of allergic reactions to multiple fungal proteins in patients with sensitivity to Alternaria [41]. Also, all the structures associated with A. alternata presented in the table are airborne. Complementary to www.allergen.org is the database www.allergome.com [42]. The difference between the two is the rigor with which the structures are registered, so that the www.allergen.org database indicates only the structures whose allergenicity has been demonstrated, while www.allergome.com includes all the structures that could represent an allergen [43]. This database also includes Alt a 2, an allergen excluded due to contradictory results obtained in clinical studies, and Alt a 9, whose action is still incompletely elucidated [43,44,45].

Table 1.

The main allergen structures of the A. alternata species.

Allergens Biochemical Name Description Bibliographic References
Alt a 1
Major allergen
Beta-barrel protein with unique structure Primary indicator of sensitization, with a stable dimeric structure. It is located in the cell wall of the spores. Once inhaled, it causes the production of antibodies in 80% of patients sensitized to Alternaria. [46,47,48]
Alt a 3 Heat shock protein It protects cells from oxidative and thermal stress. The presence in the serum of sensitized patients is 5%. [43]
Alt a 4 Disulfide isomerase As a recombinant protein, it reacts with specific IgE antibodies in the serum of 42% of sensitized patients. [49]
Alt a 5 Ribosomal protein P2 Component of the ribosomal subunit involved in protein synthesis, it reacts with immunoglobulin E in the serum of 8–14% of sensitized patients. [50]
Alt a 6
(previous name: Alt a 11)
Enolase Recognized in the serum of 22% of patients sensitized to Alternaria. Important due to the high rate of cross-reactivity. [51]
Alt a 7 YCP4 protein Homologous to the yeast protein, it reacts with specific immunoglobulins in the serum of 7% of sensitized patients. [52]
Alt a 8 Mannitol dehydrogenase Recognized by the serum of 41% of patients sensitized to Alternaria, it is homologous to the NADP-dependent mannitol dehydrogenase belonging to the species Cladosporium herbarum. [53]
Alt a 10 Aldehyde dehydrogenase Recognized by Alternaria specific IgE in 2% of patients. [49]
Alt a 12 Ribosomal protein P1 It is similar to Alt a 5, forms dimers together with P2, participating in protein synthesis. [49]
Alt a 13 Glutathione-S-transferase Recombinant protein with a major role in allergenicity, 14 out of 17 patients allergic to A. alternata showing positive reactions to the skin allergy test. [54]
Alt a 14 Manganese superoxide dismutase Enzyme involved in protection against oxidative stress. The serum of 11.5% of the 61 patients tested reacted positively to Alt a 14. [39]
Alt a 15 Serine protease Described as a panallergen, it reacted with a prevalence of 10.2% in the serum of sensitized patients. [39]

2.2. Cladosporium

The genus Cladosporium comprises over 750 species of fungi distributed in various indoor and outdoor habitats, disseminating spores in aquatic, terrestrial and atmospheric environments. In addition to their allergenic potential, the fungi can act as phytopathogens and, in immunocompromised individuals, can be agents triggering opportunistic infections [55,56]. Spores from fungi of this genus tend to dominate bioaerosols in the atmospheric environment, with concentrations ranging from 1 to 10,000 spores/cubic meter of air. Once inhaled, they lead to irritation of the respiratory tract and the onset of respiratory allergies [57].

The two most important species involved in triggering hypersensitivity reactions are Cladosporium herbarum and Cladosporium cladosporioides. C. herbarum is a common contaminant in clinical laboratories and has been associated with various diseases, including pulmonary mycotoxicosis. C. cladosporioides, a common saprophytic species, can cause skin and lung infections. However, this species also has beneficial properties, acting as an antibiotic agent against microorganisms such as Escherichia coli, Bacillus subtilis and Candida albicans, and having possible insecticidal effects [58]. Table 2 presents the main clinically relevant allergens retrieved from the www.allergen.org database, grouped according to origin. From a biochemical point of view, the structures involved in the allergenicity of fungi of the genus Cladosporium are enzymes (vacuolar serine protease, transaldolase, enolase, mannitol dehydrogenase, aldehyde dehydrogenase) or proteins (glycoprotein, ribosomal proteins P1 and P2, YCP4 protein).

Table 2.

The main allergen structures of the Cladosporium genus.

Allergens Biochemical Name Species Description Bibliographic References
Cla c 9 Vacuolar serine protease C. cladosporioides Protein with a high degree of cross-reactivity with serine proteases from Penicillium chrysogenum and Aspergillus fumigatus [59,60]
Cla c 14 Transaldolase C. cladosporioides Transaldolase with high cross-reactivity to which specific antibodies in the serum of 38% of patients with hypersensitivity to Cladosporium react. [61]
Cla h 2 Glycoprotein C. herbarum Small allergen, existing in multiple isoallergenic forms. [62]
Cla h 5/Cla h 4 Ribosomal protein P2 C. herbarum The study conducted on 62 patients sensitized to C. herbarum showed that the serum of 22% reacted positively by binding specific IgE to Cla h 4. [49]
Cla h 6 Enolase C. herbarum The study conducted on 62 patients sensitized to C. herbarum showed that the serum 20% of them reacted positively by binding specific IgE to Cla h 6. [49]
Cla h 7 YCP4 protein C. herbarum The study conducted on 62 patients sensitized to C. herbarum showed that the serum of 22% reacted positively by binding specific IgE to Cla h 7. [49]
Cla h 8 Mannitol dehydrogenase C. herbarum Major allergen to which 57% of patients with Cladosporium allergy react. [63]
Cla h 9 Vacuolar serine protease C. herbarum Cladosporium allergy, the serum of 15.5% reacted positively by binding specific IgE antibodies to Cla h 9. [64]
Cla h 10/Cla h 3 Aldehyde dehydrogenase C. herbarum The study conducted on 62 patients sensitized to C. herbarum showed that the serum of 38% of them reacted positively by binding specific IgE to Cla h 10. [49]
Cla h 12 Ribosomal protein P1 C. herbarum Allergen discovered in the 1990s using recombinant technology. [60]

2.3. Aspergillus

The genus Aspergillus comprises over 200 species—339 known, of which 20 are pathogenic to humans. They are saprophytes and have their habitat in the soil [65,66]. Among the filamentous fungi, species belonging to the genus Aspergillus have been frequently associated with the induction of asthma and other allergic respiratory problems. More than 80% of these diseases are caused by Aspergillus fumigatus [27]. The exact mechanism behind allergic airway diseases induced by A. fumigatus remains uncertain, although there are theories according to which the mycelium and conidia of Aspergillus may persist in the airways long enough to release antigens that affect ciliary function and/or lead to damage to the lung structure [67]. The first cells to come into contact with inhaled conidia are the bronchial epithelial cells, which secrete antimicrobial compounds to protect the airways [68]. At this level, Aspergillus secretes sialic acid residues, which are thought to be able to shape the airway epithelium, as studies show that pathogenic Aspergillus species have a higher concentration of sialic acid than non-pathogenic species [69]. The airway epithelium is, in this case, a factor in the pathogenesis of asthma and allergic diseases [67]. In addition to allergic bronchopulmonary aspergillosis (ABPA), Aspergillus is known to produce toxins such as aflatoxin and gliotoxin. Gliotoxin promotes fungal entry into lung epithelial cells and suppresses host immune responses, and aflatoxin is ingested through contaminated food [70].

Aspergillus species with allergenic potential are Aspergillus niger, Aspergillus flavus, Aspergillus versicolor, Aspergillus oryzae. Table 3 presents a selection of the main allergenic substances of the listed species, recognized as having clinical relevance, retrieved from the database www.allergen.org. The proteins, enzymes and the FG-GAP domain are ordered according to their origin. The descriptions focus on allergenicity in the context of asthma or ABPA, an inflammatory disease caused by immunological reactions that occur when immunocompromised patients’ airways are colonized with A. fumigatus [71]. There are also notes regarding the potential for cross-reactivity.

Table 3.

The main allergens of the genus Aspergillus.

Allergens Biochemical Name Species Description Bibliographic References
Asp fl 13 Alkaline serine protease A. flavus 63% binding capacity of specific antibodies indicating Aspergillus allergy. [72]
Asp f 1 Miogilin family protein A. fumigatus 85% binding capacity of specific antibodies indicating Aspergillus allergy. [73]
Asp f 2 PRA-1 related protein A. fumigatus Associated with patients suffering from allergic bronchopulmonary aspergillosis. [74]
Asp f 3 Peroxisomal protein A. fumigatus 72% binding capacity of specific antibodies indicating Aspergillus allergy. [75]
Asp f 4 Protein of unknown function A. fumigatus IgE binding to rAsp f 4 is very common in ABPA (92%). [76]
Asp f 5 Metalloprotease A. fumigatus Of the 54 patients with ABPA, 93% showed IgE binding to rAsp f 5 in the ELISA test. [77]
Asp f 8 Acidic ribosomal protein P2 A. fumigatus Intercellular allergen, recognized by the body of patients suffering from ABPA. [78]
Asp f 9 Cell wall-associated glycosidase Crf1 A. fumigatus IgE binding to rAsp f 9 is common in ABPA (89%). [79]
Asp f 11 Peptidyl-prolyl isomerase A. fumigatus The IgE response to rAsp f 11 is very common in patients sensitized to A. fumigatus (90%). [80]
Asp f 12 Heat shock protein P90 A. fumigatus The allergen plays an important role in triggering caspofungin resistance in A. fumigatus. [81]
Asp f 13
(associated with Asp f 15)
Alkaline serine protease A. fumigatus Extracellular elastolytic protease plays a major role in the pathogenesis of invasive aspergillosis and increases airway hyperresponsiveness. [82,83]
Asp f 16 Cell wall-associated glycosidase Crf1 A. fumigatus IgE binding to rAsp f 16 is common in ABPA (70%). [74]
Asp f 18 Vacuolar serine protease A. fumigatus IgE binding to Asp f 18 is common (79%) among asthmatic patients sensitized to A. fumigatus. [84]
Asp f 22 Enolase A. fumigatus 30% of asthmatic patients sensitized to Penicillium have IgE that recognize P. citrinum enolase. [85]
Asp f 27 Cyclophilin A. fumigatus IgE binding to rAsp f 27 is common (75%) among individuals sensitized to A fumigatus. [86]
Asp f 34 PhiA protein in the cell wall A. fumigatus IgE binding to rAsp f 34 is very common (93%) among ABPA patients sensitized to A. fumigatus. [87]
Asp f 35 Copper Zinc Superoxide dismutase A. fumigatus Of the 52 patients with asthma, 14 were positive in the test performed. [88]
Asp n 14 Beta-xylosidase A. niger In 11% of the 171 symptomatic bakers tested, specific anti-xylanase IgE was identified. [89]
Asp o 13 Alkaline serine protease A. oryzae Of 70 asthmatic patients, 17 showed specific antibodies to Asp o 13. Cross-reactivity with serine protease from P. citrinum was demonstrated. [90]
Asp v 13 Extracellular alkaline serine protease A. versicolor Specific IgE antibodies against Asp v 13 were identified in 8 of 40 patients allergic to A. versicolor. [91]

2.4. Penicillium

The genus Penicillium comprises over 100 species, occurring in a wide range of habitats, including air, extreme environments (in terms of salinity, temperature, pH variation and water scarcity), soil and various food products. Penicillium contaminates food and colonizes humid indoor environments. Due to their diversity and ability to survive in extreme environments, fungi have considerable potential for various applications in various fields. From a medical point of view, the genus is of particular importance due to penicillin, a molecule used as an antibiotic. Other species are used in the food industry, especially in the dairy industry [92,93].

Penicillium spores are among the most widespread aeroallergens, and their presence in damp buildings is a risk factor for asthma [56]. Studies conducted in the Taipei and Topeka areas have shown that the main species identified in homes, and therefore the species for which the study of the main allergens is necessary, are: P. citrinum, P. oxalicum, P. chrysogenum (P. notatum), P. spinulosum, P. brevicompactum [94]. A selection of the main allergenic substances of the genus Penicillium is presented in Table 4, retrieved from the database www.allergen.org. The structures have been grouped according to origin, and the description takes into account IgE reactivity or cross-reactivity.

Table 4.

The main allergens of the genus Penicillium.

Allergens Biochemical Name Species Description Bibliographic References
Pen b 13 Alkaline serine protease P. brevicompactum Out of 67 asthmatic patients, serum IgE reactivity to P. brevicompactum was detected in 11, and 10 (91%) of them recognized the Pen b 13 protein. [95]
Pen b 26 Ribosomal acidic protein P1 P. brevicompactum Allergen of interest due to the fact that, following analysis of the amino acid sequence of Pen b 26, homology with ribosomal acidic proteins P1 belonging predominantly to aeroallergens was demonstrated. [96]
Pen ch 13 Alkaline serine protease P. chrysogenum Of 70 sera from asthmatic patients, 17 showed IgE reactivity to P. chrysogenum (immunoblot); 15 of these (88%) recognized the Pen ch 13 protein. The allergen could also be directly involved in the pathogenesis of asthma. [97,98]
Pen ch 18 Vacuolar serine protease P. chrysogenum Of the 17 patients sensitized to P. chrysogenum, 14 (82%) showed IgE binding to Pen ch 18. [97]
Pen 3 Peroxisomal membrane protein P. citrinum Sera from 13 (46%) of the 28 asthmatic patients sensitized to Penicillium showed IgE binding to Pen c 3 on immunoblot. [99]
Pen c 19 Heat shock protein 70 kDa P. citrinum Penicillium allergic patients showed IgE binding to recombinant Pen c 19 and to the 70 kDa component of the P. citrinum extract. [100]
Pen c 22 Enolase P. citrinum The sera of 7 (30%) of the 23 asthmatic patients sensitized to Penicillium showed IgE binding to the Pen c 22 protein. [85]
Pen 24 Elongation factor 1 beta P. citrinum Seven (8%) of the 92 sera from patients with bronchial asthma showed IgE binding to rPen c 24. [101]
Pen c 32 Pectate lyase P. citrinum By analyzing the amino acid sequence, it was concluded that Pen c 32 shows a high degree of similarity to other fungal pectate lyases. [102]
Pen cr 26 Ribosomal phosphoprotein P1 P. crustosum 14 of 61 atopic sera (23%) from individuals sensitized to Penicillium showed positive reactions to purified Pen cr 26. [103]
Pen o 18 Vacuolar serine protease P. oxalicum Of the 70 sera from asthmatic patients tested, 18 (26%) showed IgE reactivity to P. oxalicum proteins; over 80% of these recognized Pen o 18. [97,104]

2.5. Epicoccum

Epicoccum nigrum (syn. E. purpurascens) is a common phytopathogen; in the outdoor environment it can be identified as a saprophyte of soil and plant debris, as well as an epiphyte on leaves. In indoor environments, it is found in dust and damp materials. The genus includes asexual fungi of the order Pleosporales. The spores are easily identified in air samples and, like Alternaria spores, show an increased concentration between late summer and early autumn. Epicoccum can cause allergic-mediated respiratory conditions, including allergic fungal sinusitis and hypersensitivity pneumonitis [56,105,106].

In the database www.allergen.org, only one protein with an allergen role is identified, namely Epi p 1. Serine protease with a molecular mass of 30 kDa, was purified from the species E. nigrum. It is recognized by all patients who show hypersensitivity to Epicoccum and cross-reacts with other fungal proteins, including those from the genus Alternaria [107,108].

2.6. Pithomyces/Pseudopithomyces

The genus Pithomyces includes P. chartarum, a saprophytic fungus found in soil, atmosphere, and vegetation, with both toxic and non-toxic strains. In humans, the fungus can cause onychomycosis and, through inhalation of spores, asthma [109]. Pithomyces spores can produce mycotoxins with toxic potential and possible allergic impact [110,111]. No allergen structures are registered in the www.allergen.org database, but the www.allergome.com database contains the allergen Pit m—from Pseudopithomyces maydicus—whose presence can be identified by the HIA (Halogen Immunoassay) technique [112]. There is also cross-reactivity between Pit m and Alt a 1 [60].

2.7. Torula and Rhodotorula

Torula is a genus of asexual fungi in the family Torulaceae, Ascomycota, generally saprophytic and ubiquitous in nature. It is found in moist habitats. The spores are light green or brown, have thick walls with a complex structure and a smooth surface [113,114]. Torula is frequently associated with type I allergies, causing asthma and allergic rhinitis [115]. There are no isolated allergenic structures belonging to this genus.

The genus Rhodotorula, belonging to the phylum Basidiomycota, comprises yeasts present in air, aquatic environments, soil, milk and fruit juices. The fact that species of the genus belonging to the phylum Basidiomycota can colonize humans, plants and other mammals was known, but the first infections in humans were documented after 1985 [116,117].

In addition to central nervous system infections, ocular infections, endocarditis, and peritonitis, R. mucilaginosa can cause hypersensitivity reactions [56,117]. The two allergen structures described in the www.allergen.org database are Rho m 1 and Rho m 2.

Rho m 1 is an enolase with a molecular weight of 47 kDa. Chang et al. study found that enolase-bound immunoglobulin E was identified in the serum of 21% of patients allergic to R. mucilaginosa [118]. Rho m 2 is a vacuolar serine protease with a molecular weight of 31 kDa. The same study found that immunoglobulin E against Rho m 2 was identified in the serum of 57% of patients with bronchial asthma allergic to R. mucilaginosa [119].

As it can be seen in this chapter, allergenic proteins from dominant atmospheric fungi are well characterized (Alt a 1 from A. alternata, as well as allergens from Aspergillus, Penicillium, and Cladosporium species). Numerous allergenic proteins have been described, including highly prevalent cross-reactive proteins such as enolases, ribosomal proteins, and serine proteases. The identification of the homologous and cross-reactive proteins shared among the characterized taxa suggests that allergic responses associated to common airborne fungi may overlap. In contrast to the dominant fungi, however, data regarding the molecular structures, sensitization pathways, and immunological action of the emerging atmospheric genera remain highly limited. Although the allergenic structures of genera such as Torula, Rhodotorula, Epicoccum and Pithomyces are less characterized, their presence in atmosphere and their capacity to induce hypersensitivity reactions suggest a possible underrecognized clinical relevance. Therefore, further studies are needed in order to better understand whether these genera represent independent sensitizing agents or their contribution is linked to the cross-reactive structures they share with the dominant taxa.

3. Modern Diagnostics and Methodologies

Since the 19th century, the importance of monitoring the composition of indoor and outdoor air has been recognized for the diagnosis, screening and treatment of allergic patients. The first method used to quantify fungal spores was cultivation and microscopic analysis. Although still widely used, there are a number of shortcomings: the method is selective, since only taxa that can grow on standard culture media can be detected. Also, only viable spores can be cultured. Another drawback is the difficulty of distinguishing taxa with common characteristics by simple optical analysis [120]. To overcome these difficulties, new techniques have been studied and described in the literature.

Airborne particles can be quantified by passive or active methods [121]. The passive method, based on gravity (sedimentation), consists of collecting biological material on a Petri dish or on a glass slide exposed to a determined environment for a fixed period of time. Although it is simple to apply, the technique has major limitations, since it does not allow the concentration to be reported to a standardized air volume and is influenced by the shape and size of the fungal spores, small aeroallergens being difficult to capture [122]. In contrast, active volumetric methods allow the precise quantification of small particles reported to the air volume by means of filtration, impaction and impingement devices [123,124,125]. Separation from the air in the volumetric method is based on the inertia of the particles. Depending on the particle storage environment, the devices can be of the impactor (solid medium) or impinger (liquid medium) type [121]. They collect microorganisms either selective, on culture media that require incubation, or nonselective, on adhesive surfaces that allow direct microscopic analysis of viable and nonviable particles, providing a rapid insight into air quality. Filtering devices retain particles on specific membranes for subsequent analysis, the efficiency of which is directly dependent on the type of filter and pore size [122,126]. While outdoor environments are monitored standardized by Hirst-type traps to capture seasonal and circadian dynamics, in indoor environments cascade impactors (e.g., Andersen impactors) or filtration systems are preferred, capable of identifying local sources of contamination and assessing air quality in enclosed spaces [122,127].

The enzyme-linked immunosorbent assay (ELISA) technique uses the properties of enzymes to detect and quantify antigen-antibody reactions through color changes [128]. Currently, this technique is successfully used to detect and quantify major allergenic proteins such as Alt a 1 and Asp f 1 [129]. The study by Sander et al., 2012 [130], demonstrated the potential of ELISA to measure airborne fungal spores and differentiate taxa. However, there are limitations related to the lack of standardized extracts [131].

The FTIR (Fourier transform infrared) technique is a noninvasive method for analyzing biological samples that quantifies the natural vibrations of molecular bonds, measurable by IR spectroscopy. Thus, information on the molecular composition is obtained without damaging the analyzed specimen [132]. The study conducted by Zimmermann et al., 2015 [133], aimed to study fungal spores and pollen using FTIR. Clear differentiations were obtained between species and between pollen and spores. Preserved spores were analyzed, the results indicating the preservation of the chemical composition.

The fHIA (fluorescent halogen immunoassay) technique is based on the principle of immunofluorescence. The study by Green et al., 2009 [134], highlights the usefulness of the technique because multiple aeroallergens have been characterized and a broader spectrum of fungi that can induce allergic reactions has been identified. The combination of serological and environmental analyses proposed by the authors provides a broad picture of the allergens to which the patient is exposed and can significantly improve the clinical course.

Another emerging and modern diagnostic method is the use of biosensors, analytical instruments that detect and quantify specific substances by coupling a biomolecule to a transducer. Their advantages include real-time monitoring, increased specificity, and sensitivity [135]. Future directions for this technology include the integration of artificial intelligence for data interpretation [136]. A synthesis of the methods is described in Table 5, along with the advantages and limitations.

Table 5.

Methods of quantification of fungi allergens.

Method Principle Advantages Limitations
Cultivation and
microscopic analysis
Growth and optical identification of spores Accessibility Selectiveness and subjectivity of analysis
Passive methods Sedimentation by gravity force Simple to apply No standardized air volume
Influenced by shape and size of the spores
Active volumetric methods Particles inertia; filtration,
impaction and impingement
Standardized air volume Dependable on the equipment
ELISA Quantification of antigen-antibody reactions through color changes Measurement and
differentiation of taxa
Lack of standardized extracts
FTIR Quantification of the natural vibrations of molecular bonds Non-invasive Need of special equipment
fHIA Immunofluorescence Significant improvement in treatment Need of special equipment
Biosensors Detection and quantification by coupling a biomolecule to a transductor Real-time monitoring, increased specificity and sensibility Emerging technique that has not been clinical validated yet

Allergen immunotherapy (AIT) is a method of treating hypersensitivity that has been used since the early 1900s [137]. The term “allergen extract” refers to glycoproteins or proteins that have not yet been processed in therapeutic treatment, as it is prepared specifically for each patient to reduce the risk of contamination [138]. The issue of standardizing extracts has been long debated, as natural products are more difficult to compare than synthetic ones [139].

The first step in standardization is to ensure quality, efficacy and safety by using analytical methods. According to European standards, the parameter analyzed is the measurement of the specific binding capacity of IgE immunoglobulins. The second step is to make comparisons between allergen extracts from the same allergen, but from different manufacturers [140]. Homologous allergens are established based on the identity of the amino acid sequences of the allergenic proteins [141].

4. Geographical Distribution and Seasonality

Through studies conducted in different regions, climates and environments, the selected taxa are proven to be significant components in the atmosphere, either by the high concentration of spores or by their constant character. The geographical distribution of the taxa analyzed confirms their ubiquity, being identified from tropical areas to polar regions. Although the presence in the atmosphere varies depending on the season, the genera Cladosporium and Alternaria remain the dominant constants [111,142,143].

Alternaria, Epicoccum, Torula and Cladosporium spores were recorded under conditions of high temperature and low humidity [144]. In Portugal, a one-year seasonal distribution analysis of the city of Porto identified high concentrations of Alternaria and Cladosporium spores during autumn and winter. The most abundant taxa in the atmosphere were Cladosporium (74.5%), Aspergillaceae (2.9%) and Alternaria (1.3%) [145]. In Granada, Spain, 93.82% of the identified fungal spores belonged to the genus Cladosporium and a strong correlation was obtained between temperature and light and the concentration of spores belonging to the dominant genera [146]. In Bratislava, of the 53 airborne fungal taxa, Cladosporium spores were the most frequent. The highest concentrations were recorded in summer and autumn [147]. In France, a study conducted over a 4-year period indicates, among the dominant taxa in the atmosphere, Alternaria and Cladosporium [148].

A study conducted in Singapore over a 5-year period records increased concentrations of Cladosporium and Pithomyces spores [149]. The study conducted by Kumar & Attri, 2016 [150] over a period of 14 months, in a region of the Himalayas, records the presence of spores belonging to the fungi of the genera Cladosporium, Alternaria, Torula, Pithomyces, Epicoccum. In Kuwait, high concentrations of Cladosporium, Alternaria, Aspergillus/Penicillium were recorded [151]. In Wuhan, China, the genera Cladosporium, Aspergillus, Alternaria, and Penicillium predominate [152].

A significant number of the United States population are sensitized to fungal aeroallergens including Aspergillus, Epicoccum, Cladosporium, Penicillium, and Alternaria [153]. In Havana, Cuba, between November 2010 and October 2011, the predominant taxon in the atmosphere was Cladosporium, with 148,717 spores identified, followed by Aspergillus/Penicillium spores [154]. In La Plata, Argentina, Alternaria and Cladosporium predominate in the atmosphere [155].

In Antarctica, the study by Gonçalves et al., 2017 [156], identified the presence of opportunistic genera Penicillium, Rhodotorula and Cladosporium on rocks in cold climates. In the ice cap, the genera Cladosporium, Penicillium and Epicoccum were identified, and species belonging to Penicillium and Rhodotorula were isolated from snow samples. [157]. In South Africa, the study by Ajikah et al., 2023 [158], shows that in Johannesburg the dominant fungal genera in the atmosphere include not only the dominant taxa Penicillium/Aspergillus, Alternaria and Cladosporium, but also the undercharacterized ones: Torula and Epicoccum. The study by Ndjindji et al., 2023 [159], regarding allergic sensitization in adults and children in Africa indicates allergic sensitization to the dominant taxa Aspergillus, Cladosporium, Penicillium and Alternaria. In Australia, studies indicate an increased prevalence of Cladosporium and Alternaria spores in the atmosphere [160,161].

The broad geographical distribution of atmospheric fungi, both dominant and undercharacterized, suggests that exposure to fungal spores represents a global environmental and public health issue. Although genera such as Cladosporium, Alternaria, Aspergillus and Penicillium remain dominant in most regions, studies from different climatic areas also indicate the constant presence of lesser explored fungi including Epicoccum, Pithomyces, Torula and Rhodotorula. Climatic variations may influence not only the concentration of airborne spores, but also the seasonal dynamics and regional prevalence of different fungal genera. In this context, environmental changes may contribute to modifications in exposure patterns and sensitization profiles, particularly in urban populations exposed simultaneously to air pollutants and mixed fungal aeroallergens. The increasing detection of undercharacterized taxa in geographically distant regions may also suggest that their clinical importance is currently underestimated.

5. Impact on Public Health

It is estimated that, globally, 30% of the population suffers from hypersensitivity, and between 3% and 10% suffer from an allergy caused by fungal spores [162,163]. Sensitization can begin as early as childhood, and the clinical course depends on the living environment, the degree of urbanization, the workplace and climatic conditions [162,164,165]. Studies show that bioaerosols may represent a risk factor for people with a weak immune system [166]. Inhalation of indoor or outdoor air exposes the body to airborne fungi, which can lead to the onset of respiratory pathology [167].

In the outdoor environment, the correlation between the increase in the concentration of spores in the atmosphere and the exacerbation of asthma symptoms is positive. In the fall, for example, the number of doctor visits due to pediatric asthma increases, and during storms, asthma attacks are more frequent [165,168]. Due to air circulation, the main source of indoor fungi is outdoor air. Fungi reach buildings through ventilation and heating systems or through contamination of materials [169]. The phrase “Sick Building Syndrome” refers to the phenomenon that occurs when a person develops unusual symptoms while working in a certain space. Symptoms include wheezing, irritation of the mucous membrane of the eyes and rhinitis, and conditions that favor the growth of fungi in indoor environments are high humidity and temperature [167,170]. Early exposure to interior dampness is often associated with the onset of asthma, and people who live in such environments are at increased risk of developing the disease [168]. Epidemiologically, indoor exposure to musty odors and dampness is directly correlated with the development of allergic rhinitis [171]. Hypersensitivity pneumonitis occurs following recurrent exposure to airborne allergens and is characterized by dyspnea, fever, and in the chronic stage can lead to pulmonary fibrosis [172].

Although indirect, the impact that fungi have on public health can also be inferred from general and medical interest, reflected in the quantity and quality of studies published in the last two and a half decades. In the following part, a bibliometric analysis of articles published between 2000 and 2025 will be presented. The databases used for the searches are Google Scholar (excluding citations and patents) and PubMed. The period of interest chosen was the interval 2000–2025. Specific search terms were used, combined in English, in the form: “fungal airborne allergens”, “[genus] fungi allergen”, where the genera analyzed were: Alternaria, Cladosporium, Aspergillus, Penicillium, Epicoccum, Pithomyces, Torula and Rhodotorula. Table 6 lists the taxa of interest and the corresponding search term. For each search term, the total number of results returned by each database and the annual distribution of publications were recorded. The data obtained were centralized using Microsoft Excel and graphically represented to highlight temporal trends and differences between Google Scholar and PubMed, as detailed in the subsections below.

Table 6.

Searching terminology used.

Genera Bibliographic Reference Searching Term
Alternaria [173] Alternaria fungi allergen
Cladosporium [144] Cladosporium fungi allergen
Aspergillus [66] Aspergillus fungi allergen
Penicillium [24] Penicillium fungi allergen
Epicoccum [56] Epicoccum fungi allergen
Pithomyces [174] Pithomyces fungi allergen
Torula [175] Torula fungi allergen
Rhodotorula [118] Rhodotorula fungi allergen

5.1. Quantitative Trends

The search term “Fungal airborne allergens” generated 17,900 results in Google Scholar and 464 in PubMed, for the period 2000–2025 (Figure 1). While in Google Scholar the trend is upward (y = 93.886, with a strong correlation), in PubMed the number of articles fluctuates. For the dominant genera of fungi, Google Scholar shows an increasing trend, while the emerging genera mostly stagnate. Although the number of PubMed studies is lower, the same pattern of dominance can be observed. Moreover, the difference between the number of results is astonishing, going from 17,900 of articles referring to Alternaria in Google Scholar, to 928 articles about Pithomyces (Figure 2).

Figure 1.

Figure 1

Temporal distribution of articles in Google Scholar (a) and PubMed (b).

Figure 2.

Figure 2

General number of articles for each search term in the 2000–2025 time period.

Academic interest in the Alternaria taxon is supported quantitatively and qualitatively by the increase in the number of articles in Google Scholar. The trend in PubMed is positive, but almost stagnant. With a lower number of articles for Cladosporium than for Alternaria, Google Scholar data indicates a quantitative increase in publications over time, while PubMed records a slight decrease, but without statistical relevance (R2 = 0.0627).

The search for the terms “Aspergillus fungi allergen” yielded a considerable volume of literature in both Google Scholar and PubMed; however, the upward trend in Google Scholar is not maintained in PubMed. The taxon Penicillium is the one with the highest number of articles recorded in the analysis for Google Scholar. In PubMed, the trend is decreasing, but without statistical relevance (R2 = 0.0709).

The growth of articles on Epicoccum was slightly fluctuating between 2000 and 2025. Quantitatively, however, the discrepancy between Epicoccum and the dominant genera is significant. In the case of the genus Torula, the number of articles is reduced, but with an upward trend in Google Scholar. In PubMed, a trend of stagnation is indicated, but with low statistical value, the value of R2 being 0.1181. In the case of Rhodotorula, there is a slight increase in the number of articles in Google Scholar, while in PubMed the trend is stagnant. The taxon with the lowest number of results is Pithomyces. Although there is a slight increase in Google Scholar, there are only 7 articles in PubMed.

5.2. Qualitative Trends

The qualitative distribution of studies (Figure 3) sustains the undercharacterization of the emerging genera, most articles from Google Scholar being unindexed, compared to the dominant genera, where Q1 is frequent. From a qualitative point of view, the published studies for the general term “Fungal airborne allergens” belong predominantly to the Q1 quartile for both search engines, indicating a rigor of the published literature. For Alternaria, 33% of the articles in Google Scholar and 39% in PubMed belong to the Q1 quartile, indicating the dominance of specialized literature in both the public and medical fields. In the case of Cladosporium, the predominant percentage in Google Scholar belongs to articles indexed in quartiles, and in PubMed the dominant quartile is Q3. The data show heterogeneity in literature quality. The Aspergillus genera had most of the articles in the first quartile, indicating a high-quality body of literature. The distribution is heterogeneous in Google Scholar for Penicillium, with both Q1 and unindexed articles covering the same percentage, while PubMed shows predominance of Q1.

Figure 3.

Figure 3

Quartile distribution of articles in Google Scholar (a) and PubMed (b).

In the case of Epicoccum, 44% of studies in Google Scholar are not indexed, and 41% of studies in PubMed are Q1 indexed. For Torula, 66% of articles in Google Scholar are not indexed, and 44% of articles in PubMed belong to quartile Q1. This picture captures a more solid medical basis than the informational foundation of the general public and shows the need for in-depth research to confirm the allergenic potential discussed in the existing literature. The case of Rhodothorula shows that 44% of the articles in Google Scholar are unindexed, and in PubMed the distribution is equal for unindexed articles and Q1 (36% each). The last genera, Pithomyces, has most of the articles unindexed or indexed in Q4, indicating undercharacterization.

5.3. Thematic Trends

From a thematic point of view, the articles focus on the seasonal distribution of fungal spores and their role in allergic pathology. For Alternaria, the articles have as main themes the effect of the fungus on the body and the major allergen Alt a 1. Searches on Cladosporium led by articles that dealt with allergenicity of both dominant taxa, Cladosporium and Alternaria. The majority of the topics on Aspergillus are related to allergic bronchopulmonary aspergillosis. In the case of Penicillium, the topics addressed focus on the effects of allergens of different species of the genus on the body and on cross-reactivity. Articles about Epicoccum focus on cross-reactivity. The themes of the articles situate Rhodotorula and Torula as emerging genera with a role in hypersensitivity. Given the prevailing theme demonstrating the pathogenicity of the genus Pithomyces for both humans and animals, a future research direction is needed to strengthen, through quality studies, the current hypotheses.

6. Conclusions

Climate change in the 21st century has affected human health by altering the allergenic potential of fungi in the atmosphere. By integrating both widely studied and undercharacterized genera, this review creates a comprehensive picture of them. Due to their constant and quantitatively significant presence in indoor and outdoor environments, fungal spores cannot be excluded from the picture of hypersensitivity. Both traditional and modern methods allow their identification and effective diagnosis.

After analyzing the specialized literature from 2000–2025, it emerged that the airborne fungal species with the greatest impact on human health belong to the genera Alternaria, Aspergillus, Cladosporium and Penicillium. These have the most numerous results in both Google Scholar and PubMed, with an important percentage belonging to the Q1 and Q2 quartiles.

There is an obvious discrepancy between the dominant and emerging genera, which register a smaller number of articles and a qualitative mosaic in which non-indexed articles or belonging to the Q3 and Q4 quartiles predominate.

Although the role of fungi in allergic sensitization is a topic of interest for the general population, proven by the constant increase in articles in Google Scholar, quality medical studies are needed that provide a clear perspective on the taxa Epicoccum, Pithomyces, Torula and Rhodotorula. Future research should focus on comprehensive characterization of emerging fungal allergens, particularly on determining the allergenic structures of Torula species and the correlation of hypersensitivity and Pithomyces spores.

Abbreviations

The following abbreviations are used in this manuscript:

ABPA Allergic Bronchopulmonary Aspergillosis
HIA Halogen Immunoassay
ELISA Enzyme-linked Immunosorbent Assay
FTIR Fourier Transform Infrared
IR Infrared
fHIA Fluorescent Halogen Immunoassay
AIT Allergen Immunotherapy

Author Contributions

Conceptualization, N.I.; methodology, N.I.; software, N.-T.M.; validation, N.I.; investigation, N.-T.M.; resources, N.I.; data analysis, N.-T.M.; writing—original draft preparation, N.-T.M.; writing—review and editing, N.-T.M., N.I.; visualization, N.I.; supervision, N.I.; funding acquisition, N.I. All authors have read and agreed to the published version of the manuscript.

Data Availability Statement

The original contributions presented in this study are included in the article. Further inquiries can be directed to the corresponding author.

Conflicts of Interest

The authors declare no conflicts of interest.

Funding Statement

We gratefully acknowledge the support provided by the West University of Timișoara through the grant “Research Career Guidance and Counseling Center—Western Region”, funded by the Romanian Ministry of Research, Innovation and Digitalization via Romania’s National Recovery and Resilience Plan, Call No. PNRR-III-C9-2022-I10.

Footnotes

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

References

  • 1.Matthias-Maser S., Jaenicke R. The size distribution of primary biological aerosol particles with radii >0.2 μm in an urban/rural influenced region. Atmos. Res. 1995;39:279–286. doi: 10.1016/0169-8095(95)00017-8. [DOI] [Google Scholar]
  • 2.Grinn-Gofroń A., Strzelczak A. The effects of meteorological factors on the occurrence of Ganoderma sp. spores in the air. Int. J. Biometeorol. 2011;55:235–241. doi: 10.1007/s00484-010-0329-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.d’Amato G. Environmental urban factors (air pollution and allergens) and the rising trends in allergic respiratory diseases. Allergy. 2002;57:30–33. doi: 10.1034/j.1398-9995.57.s72.5.x. [DOI] [PubMed] [Google Scholar]
  • 4.d’Amato G., Pawankar R., Vitale C., Lanza M., Molino A., Stanziola A., Sanduzzi A., Vatrella A., d’Amato M. Climate change and air pollution: Effects on respiratory allergy. Allergy Asthma Immunol. Res. 2016;8:391–395. doi: 10.4168/aair.2016.8.5.391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Franchini M., Mannucci P.M. Impact on human health of climate changes. Eur. J. Intern. Med. 2015;26:1–5. doi: 10.1016/j.ejim.2014.12.008. [DOI] [PubMed] [Google Scholar]
  • 6.Katelaris C.H., Beggs P.J. Climate change: Allergens and allergic diseases. Intern. Med. J. 2018;48:129–134. doi: 10.1111/imj.13699. [DOI] [PubMed] [Google Scholar]
  • 7.Demain J.G., Choi Y.J., Oh J.W. The impact of climate change on the pollen allergy and sporulation of allergic fungi. Curr. Treat. Options Allergy. 2021;8:60–73. doi: 10.1007/s40521-020-00277-5. [DOI] [Google Scholar]
  • 8.Noah T.L., Worden C.P., Rebuli M.E., Jaspers I. The effects of wildfire smoke on asthma and allergy. Curr. Allergy Asthma Rep. 2023;23:375–387. doi: 10.1007/s11882-023-01090-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Reid C.E., Gamble J.L. Aeroallergens, allergic disease, and climate change: Impacts and adaptation. EcoHealth. 2009;6:458–470. doi: 10.1007/s10393-009-0261-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Pulimood T.B., Corden J.M., Bryden C., Sharples L., Nasser S.M. Epidemic asthma and the role of the fungal mold Alternaria alternata. J. Allergy Clin. Immunol. 2007;120:610–617. doi: 10.1016/j.jaci.2007.04.045. [DOI] [PubMed] [Google Scholar]
  • 11.Lam H.C., Jarvis D., Fuertes E. Interactive effects of allergens and air pollution on respiratory health: A systematic review. Sci. Total Environ. 2021;757:143924. doi: 10.1016/j.scitotenv.2020.143924. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.D’Amato G., Chong-Neto H.J., Monge Ortega O.P., Vitale C., Ansotegui I., Rosario N., Haahtela T., Galan C., Pawankar R., Murrieta-Aguttes M., et al. The effects of climate change on respiratory allergy and asthma induced by pollen and mold allergens. Allergy. 2020;75:2219–2228. doi: 10.1111/all.14476. [DOI] [PubMed] [Google Scholar]
  • 13.Haahtela T. A biodiversity hypothesis. Allergy. 2019;74:1445–1456. doi: 10.1111/all.13763. [DOI] [PubMed] [Google Scholar]
  • 14.Sampath V., Aguilera J., Prunicki M., Nadeau K.C. Mechanisms of climate change and related air pollution on the immune system leading to allergic disease and asthma. Semin. Immunol. 2023;67:101765. doi: 10.1016/j.smim.2023.101765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Chiba M., Tsuji T., Komatsu M. Therapeutic advancement in inflammatory bowel disease by incorporating plant-based diet. Transl. Gastroenterol. Hepatol. 2023;8:38. doi: 10.21037/tgh-23-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Witt C., Schubert A.J., Jehn M., Holzgreve A., Liebers U., Endlicher W. The effects of climate change on patients with chronic lung disease. A systematic literature review. Dtsch. Arztebl. Int. 2015;112:878–883. doi: 10.3238/arztebl.2015.0878. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Jenerowicz D., Silny W., Danczak-Pazdrowska W., Polanska A., Osmola-Mankowska A., Olek-Hrab K. Environmental factors and allergic diseases. Ann. Agric. Environ. Med. 2012;19:475–481. [PubMed] [Google Scholar]
  • 18.Dispenza M.C. Classification of hypersensitivity reactions. Allergy Asthma Proc. 2019;40:470–473. doi: 10.2500/aap.2019.40.4274. [DOI] [PubMed] [Google Scholar]
  • 19.Nageen Y.A., Asemoloye M.D., Põlme S. Analysis of culturable airborne fungi in outdoor environments in Tianjin, China. BMC Microbiol. 2021;21:134. doi: 10.1186/s12866-021-02205-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Gilbert G.S., Parker I.M. The Evolutionary Ecology of Plant Disease. Oxford University Press; Oxford, UK: 2023. How to be a fungus; pp. 27–52. [Google Scholar]
  • 21.Islam M.R., Tudryn G., Bucinell R., Schadler L., Picu R.C. Morphology and mechanics of fungal mycelium. Sci. Rep. 2017;7:13070. doi: 10.1038/s41598-017-13295-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Eduard W. Fungal spores: A critical review of the toxicological and epidemiological evidence as a basis for occupational exposure limit setting. Crit. Rev. Toxicol. 2009;39:799–864. doi: 10.3109/10408440903307333. [DOI] [PubMed] [Google Scholar]
  • 23.Wyatt T.T., Wösten H.A., Dijksterhuis J. Fungal spores for dispersion in space and time. Adv. Appl. Microbiol. 2013;85:43–91. doi: 10.1016/b978-0-12-407672-3.00002-2. [DOI] [PubMed] [Google Scholar]
  • 24.Fukutomi Y., Taniguchi M. Sensitization to fungal allergens: Resolved and unresolved issues. Allergol. Int. 2015;64:321–331. doi: 10.1016/j.alit.2015.05.007. [DOI] [PubMed] [Google Scholar]
  • 25.Barnes C. Fungi and atopy. Clin. Rev. Allergy Immunol. 2019;57:439–448. doi: 10.1007/s12016-019-08750-z. [DOI] [PubMed] [Google Scholar]
  • 26.Rudert A., Portnoy J. Mold allergy: Is it real and what do we do about it? Expert Rev. Clin. Immunol. 2017;13:823–835. doi: 10.1080/1744666x.2017.1324298. [DOI] [PubMed] [Google Scholar]
  • 27.Chaudhary N., Marr K.A. Impact of Aspergillus fumigatus in allergic airway diseases. Clin. Transl. Allergy. 2011;1:4. doi: 10.1186/2045-7022-1-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.DeMers M. Alternaria alternata as endophyte and pathogen. Microbiology. 2022;168:001153. doi: 10.1099/mic.0.001153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Gabriel M.F., Uriel N., Teifoori F., Postigo I., Suñén E., Martínez J. The major Alternaria alternata allergen, Alt a 1: A reliable and specific marker of fungal contamination in citrus fruits. Int. J. Food Microbiol. 2017;257:26–30. doi: 10.1016/j.ijfoodmicro.2017.06.006. [DOI] [PubMed] [Google Scholar]
  • 30.Sánchez P., Vélez-Del-Burgo A., Suñén E., Martínez J., Postigo I. Fungal allergen and mold allergy diagnosis: Role and relevance of Alternaria alternata Alt a 1 protein family. J. Fungi. 2022;8:277. doi: 10.3390/jof8030277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Burbach G.J., Heinzerling L.M., Edenharter G., Bachert C., Bindslev-Jensen C., Bonini S., Bousquet J., Bousquet-Rouanet L., Bousquet P.J., Bresciani M., et al. GA2LEN skin test study II: Clinical relevance of inhalant allergen sensitizations in Europe. Allergy. 2009;64:1507–1515. doi: 10.1111/j.1398-9995.2009.02089.x. [DOI] [PubMed] [Google Scholar]
  • 32.Salo P.M., Arbes S.J., Jr., Sever M., Jaramillo R., Cohn R.D., London S.J., Zeldin D.C. Exposure to Alternaria alternata in US homes is associated with asthma symptoms. J. Allergy Clin. Immunol. 2006;118:892–898. doi: 10.1016/j.jaci.2006.07.037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Downs S.H., Mitakakis T.Z., Marks G.B., Car N.G., Belousova E.G., Leuppi J.D., Xuan W., Downie S.R., Tobias A., Peat J.K. Clinical importance of Alternaria exposure in children. Am. J. Respir. Crit. Care Med. 2001;164:455–459. doi: 10.1164/ajrccm.164.3.2008042. [DOI] [PubMed] [Google Scholar]
  • 34.Didehdar M., Khoshbayan A., Vesal S., Darban-Sarokhalil D., Razavi S., Chegini Z., Shariati A. An overview of possible pathogenesis mechanisms of Alternaria alternata in chronic rhinosinusitis and nasal polyposis. Microb. Pathog. 2021;155:104905. doi: 10.1016/j.micpath.2021.104905. [DOI] [PubMed] [Google Scholar]
  • 35.Ma M., Redes J.L., Percopo C.M., Druey K.M., Rosenberg H.F. Alternaria alternata challenge at the nasal mucosa results in eosinophilic inflammation and increased susceptibility to influenza virus infection. Clin. Exp. Allergy. 2018;48:691–702. doi: 10.1111/cea.13123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Vélez-del-Burgo A., Sánchez P., Suñen E., Martínez J., Postigo I. Purified native and recombinant major Alternaria alternata allergen (Alt a 1) induces allergic asthma in the murine model. J. Fungi. 2021;7:896. doi: 10.3390/jof7110896. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Sundararaj R., Mathimaran A., Prabhu D. In silico approaches for the identification of potential allergens among hypothetical proteins from Alternaria alternata and its functional annotation. Sci. Rep. 2024;14:6696. doi: 10.1038/s41598-024-55463-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.WHO/IUIS Allergen Nomenclature. [(accessed on 23 April 2026)]. Available online: https://allergen.org/
  • 39.Gabriel M.F., Postigo I., Gutiérrez-Rodríguez A., Suñén E., Guisantes J.A., Fernández J., Tomaz C.T., Martínez J. Alt a 15 is a new cross-reactive minor allergen of Alternaria alternata. Immunobiology. 2016;221:153–160. doi: 10.1016/j.imbio.2015.09.014. [DOI] [PubMed] [Google Scholar]
  • 40.Bowyer P., Fraczek M., Denning D.W. Comparative genomics of fungal allergens and epitopes shows widespread distribution of closely related allergen and epitope orthologues. BMC Genom. 2006;7:251. doi: 10.1186/1471-2164-7-251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Crameri R., Zeller S., Glaser A.G., Vilhelmsson M., Rhyner C. Cross-reactivity among fungal allergens: A clinically relevant phenomenon? Mycoses. 2009;52:99–106. doi: 10.1111/j.1439-0507.2008.01644.x. [DOI] [PubMed] [Google Scholar]
  • 42.Allergome. [(accessed on 23 April 2026)]. Available online: https://allergome.org/
  • 43.Kustrzeba-Wójcicka I., Siwak E., Terlecki G., Wolańczyk-Mędrala A., Mędrala W. Alternaria alternata and its allergens: A comprehensive review. Clin. Rev. Allergy Immunol. 2014;47:354–365. doi: 10.1007/s12016-014-8447-6. [DOI] [PubMed] [Google Scholar]
  • 44.Bush R.K., Sanchez H., Geisler D. Molecular cloning of a major Alternaria alternata allergen, rAlt a 2. J. Allergy Clin. Immunol. 1999;104:665–671. doi: 10.1016/s0091-6749(99)70340-4. [DOI] [PubMed] [Google Scholar]
  • 45.Asturias J.A., Ibarrola I., Ferrer A., Andreu C., Lopez-Pascual E., Quiralte J., Florido F., Martinez A. Diagnosis of Alternaria alternata sensitization with natural and recombinant Alt a 1 allergens. J. Allergy Clin. Immunol. 2005;115:1210–1217. doi: 10.1016/j.jaci.2005.02.012. [DOI] [PubMed] [Google Scholar]
  • 46.Gutiérrez-Rodríguez A., Postigo I., Guisantes J.A., Suñén E., Martínez J. Identification of allergens homologous to Alt a 1 from Stemphylium botryosum and Ulocladium botrytis. Med. Mycol. 2011;49:892–896. doi: 10.3109/13693786.2011.576350. [DOI] [PubMed] [Google Scholar]
  • 47.Twaroch T.E., Arcalís E., Sterflinger K., Stöger E., Swoboda I., Valenta R. Predominant localization of the major Alternaria allergen Alt a 1 in the cell wall of airborne spores. J. Allergy Clin. Immunol. 2012;129:1148–1149. doi: 10.1016/j.jaci.2011.10.008. [DOI] [PubMed] [Google Scholar]
  • 48.Chruszcz M., Chapman M.D., Osinski T., Solberg R., Demas M., Porebski P.J., Majorek K.A., Pomés A., Minor W. Alternaria alternata allergen Alt a 1: A unique β-barrel protein dimer found exclusively in fungi. J. Allergy Clin. Immunol. 2012;130:241–247.e9. doi: 10.1016/j.jaci.2012.03.047. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Achatz G., Oberkofler H., Lechenauer E., Simon B., Unger A., Kandler D., Ebner C., Prillinger H., Kraft D., Breitenbach M. Molecular cloning of major and minor allergens of Alternaria alternata and Cladosporium herbarum. Mol. Immunol. 1995;32:213–227. doi: 10.1016/0161-5890(94)00108-d. [DOI] [PubMed] [Google Scholar]
  • 50.Simon-Nobbe B., Denk U., Pöll V., Rid R., Breitenbach M. The spectrum of fungal allergy. Int. Arch. Allergy Immunol. 2008;145:58–86. doi: 10.1159/000107578. [DOI] [PubMed] [Google Scholar]
  • 51.Simon-Nobbe B., Probst G., Kajava A.V., Oberkofler H., Susani M., Crameri R., Ferreira F., Ebner C., Breitenbach M. IgE-binding epitopes of enolases, a class of highly conserved fungal allergens. J. Allergy Clin. Immunol. 2000;106:887–895. doi: 10.1067/mai.2000.110799. [DOI] [PubMed] [Google Scholar]
  • 52.Breitenbach M., Simon-Nobbe B. The allergens of Cladosporium herbarum and Alternaria alternata. Chem. Immunol. 2002;81:48–72. doi: 10.1159/000058862. [DOI] [PubMed] [Google Scholar]
  • 53.Schneider P.B., Denk U., Breitenbach M., Richter K., Schmid-Grendelmeier P., Nobbe S., Himly M., Mari A., Ebner C., Simon-Nobbe B. Alternaria alternata NADP-dependent mannitol dehydrogenase is an important fungal allergen. Clin. Exp. Allergy. 2006;36:1513–1524. doi: 10.1111/j.1365-2222.2006.02582.x. [DOI] [PubMed] [Google Scholar]
  • 54.Shankar J., Singh B.P., Gaur S.N., Arora N. Recombinant glutathione-S-transferase: A major allergen from Alternaria alternata for clinical use in allergy patients. Mol. Immunol. 2006;43:1927–1932. doi: 10.1016/j.molimm.2005.12.006. [DOI] [PubMed] [Google Scholar]
  • 55.Ogórek R., Lejman A., Pusz W., Miłuch A., Miodyńska P. Characteristics and taxonomy of Cladosporium fungi. Mikol. Lek. 2012;19:80–85. [Google Scholar]
  • 56.Levetin E., Horner W.E., Scott J.A. Environmental Allergens Workgroup. Taxonomy of allergenic fungi. J. Allergy Clin. Immunol. Pract. 2016;4:375–385. doi: 10.1016/j.jaip.2015.10.012. [DOI] [PubMed] [Google Scholar]
  • 57.Weryszko-Chmielewska E. Health hazards related to conidia of Cladosporium—Biological air pollutants in Poland, central Europe. J. Environ. Sci. 2017;65:271–281. doi: 10.1016/j.jes.2017.02.018. [DOI] [PubMed] [Google Scholar]
  • 58.Ndlangalavu G. Doctoral Dissertation. Stellenbosch University; Stellenbosch, South Africa: 2019. The Prevalence of Cladosporium Species in Indoor Environments. [Google Scholar]
  • 59.Chou H., Tam M.F., Lee L.H., Chiang C.H., Tai H.Y., Panzani R.C., Shen H.D. Vacuolar serine protease is a major allergen of Cladosporium cladosporioides. Int. Arch. Allergy Immunol. 2008;146:277–286. doi: 10.1159/000121462. [DOI] [PubMed] [Google Scholar]
  • 60.Kespohl S., Raulf M. Mould allergens: Where do we stand with molecular allergy diagnostics? Part 13 of the series Molecular Allergology. Allergo J. Int. 2014;23:120–125. doi: 10.1007/s40629-014-0014-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Chou H., Tam M.F., Chiang C.H., Chou C.T., Tai H.Y., Shen H.D. Transaldolases are novel and immunoglobulin E cross-reacting fungal allergens. Clin. Exp. Allergy. 2011;41:739–749. doi: 10.1111/j.1365-2222.2011.03698.x. [DOI] [PubMed] [Google Scholar]
  • 62.Aukrust L., Borch S.M. Partial purification and characterization of two Cladosporium herbarum allergens. Int. Arch. Allergy Appl. Immunol. 1979;60:68–79. doi: 10.1159/000232324. [DOI] [PubMed] [Google Scholar]
  • 63.Simon-Nobbe B., Denk U., Schneider P.B., Radauer C., Teige M., Crameri R., Hawranek T., Lang R., Richter K., Schmid-Grendelmeier P., et al. NADP-dependent mannitol dehydrogenase, a major allergen of Cladosporium herbarum. J. Biol. Chem. 2006;281:16354–16360. doi: 10.1074/jbc.M513638200. [DOI] [PubMed] [Google Scholar]
  • 64.Pöll V., Denk U., Shen H.D., Panzani R.C., Dissertori O., Lackner P., Hemmer W., Mari A., Crameri R., Lottspeich F., et al. The vacuolar serine protease, a cross-reactive allergen from Cladosporium herbarum. Mol. Immunol. 2009;46:1360–1373. doi: 10.1016/j.molimm.2008.11.017. [DOI] [PubMed] [Google Scholar]
  • 65.Perrone G., Gallo A. Aspergillus species and their associated mycotoxins. In: Moretti A., Susca A., editors. Mycotoxigenic Fungi: Methods in Molecular Biology. Volume 1542. Humana Press; New York, NY, USA: 2017. pp. 33–49. [DOI] [PubMed] [Google Scholar]
  • 66.Latgé J.P., Chamilos G. Aspergillus fumigatus and Aspergillosis in 2019. Clin. Microbiol. Rev. 2019;33:e00140-18. doi: 10.1128/CMR.00140-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Ghosh S., Hoselton S.A., Schuh J.M. Allergic inflammation in Aspergillus fumigatus-induced fungal asthma. Curr. Allergy Asthma Rep. 2015;15:59. doi: 10.1007/s11882-015-0561-x. [DOI] [PubMed] [Google Scholar]
  • 68.Roy R.M., Klein B.S. Fungal glycan interactions with epithelial cells in allergic airway disease. Curr. Opin. Microbiol. 2013;16:404–408. doi: 10.1016/j.mib.2013.03.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Hamilton A.J., Jeavons L., Youngchim S., Vanittanakom N. Recognition of fibronectin by Penicillium marneffei conidia via a sialic acid-dependent process and its relationship to the interaction between conidia and laminin. Infect. Immun. 1999;67:5200–5205. doi: 10.1128/IAI.67.10.5200-5205.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Shankar J. An overview of toxins in Aspergillus associated with pathogenesis. Int. J. Life Sci. Biotechnol. Pharma Res. 2013;2:16–31. [Google Scholar]
  • 71.Agarwal R., Sehgal I.S., Dhooria S., Muthu V., Prasad K.T., Bal A., Aggarwal A.N., Chakrabarti A. Allergic bronchopulmonary aspergillosis. Indian J. Med. Res. 2020;151:529–549. doi: 10.4103/ijmr.ijmr_1187_19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Chou H., Lin W.L., Tam M.F., Wang S.R., Han S.H., Shen H.D. Alkaline serine proteinase is a major allergen of Aspergillus flavus, a prevalent airborne Aspergillus species in the Taipei area. Int. Arch. Allergy Immunol. 1999;119:282–290. doi: 10.1159/000024205. [DOI] [PubMed] [Google Scholar]
  • 73.Arruda L.K., Platts-Mills T.A., Fox J.W., Chapman M.D. Aspergillus fumigatus allergen I, a major IgE-binding protein, is a member of the mitogillin family of cytotoxins. J. Exp. Med. 1990;172:1529–1532. doi: 10.1084/jem.172.5.1529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Banerjee B., Greenberger P.A., Fink J.N., Kurup V.P. Immunological characterization of Asp f 2, a major allergen from Aspergillus fumigatus associated with allergic bronchopulmonary aspergillosis. Infect. Immun. 1998;66:5175–5182. doi: 10.1128/IAI.66.11.5175-5182.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Hemmann S., Blaser K., Crameri R. Allergens of Aspergillus fumigatus and Candida boidinii share IgE-binding epitopes. Am. J. Respir. Crit. Care Med. 1997;156:1956–1962. doi: 10.1164/ajrccm.156.6.9702087. [DOI] [PubMed] [Google Scholar]
  • 76.Kurup V.P., Banerjee B., Hemmann S., Greenberger P.A., Blaser K., Crameri R. Selected recombinant Aspergillus fumigatus allergens bind specifically to IgE in ABPA. Clin. Exp. Allergy. 2000;30:988–993. doi: 10.1046/j.1365-2222.2000.00837.x. [DOI] [PubMed] [Google Scholar]
  • 77.Crameri R. Recombinant Aspergillus fumigatus allergens: From the nucleotide sequences to clinical applications. Int. Arch. Allergy Immunol. 1998;115:99–114. doi: 10.1159/000023889. [DOI] [PubMed] [Google Scholar]
  • 78.Schwienbacher M., Israel L., Heesemann J., Ebel F. Asp f6, an Aspergillus allergen specifically recognized by IgE from patients with allergic bronchopulmonary aspergillosis, is differentially expressed during germination. Allergy. 2005;60:1430–1435. doi: 10.1111/j.1398-9995.2005.00904.x. [DOI] [PubMed] [Google Scholar]
  • 79.Crameri R. Disease-specific recombinant allergens for the diagnosis of allergic bronchopulmonary aspergillosis. Int. Immunol. 1998;10:1211–1216. doi: 10.1093/intimm/10.8.1211. [DOI] [PubMed] [Google Scholar]
  • 80.Flückiger S., Fijten H., Whitley P., Blaser K., Crameri R. Cyclophilins, a new family of cross-reactive allergens. Eur. J. Immunol. 2002;32:10–17. doi: 10.1002/1521-4141(200201)32:1<10::AID-IMMU10>3.0.CO;2-I. [DOI] [PubMed] [Google Scholar]
  • 81.Lamoth F., Juvvadi P.R., Gehrke C., Asfaw Y.G., Steinbach W.J. Transcriptional activation of heat shock protein 90 mediated via a proximal promoter region as trigger of caspofungin resistance in Aspergillus fumigatus. J. Infect. Dis. 2014;209:473–481. doi: 10.1093/infdis/jit530. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Kolattukudy P.E., Lee J.D., Rogers L.M., Zimmerman P., Ceselski S., Fox B., Stein B., Copelan E.A. Evidence for possible involvement of an elastolytic serine protease in aspergillosis. Infect. Immun. 1993;61:2357–2368. doi: 10.1128/iai.61.6.2357-2368.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Balenga N., Klichinsky M., Xie Z. A fungal protease allergen provokes airway hyper-responsiveness in asthma. Nat. Commun. 2015;6:6763. doi: 10.1038/ncomms7763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Shen H.D., Lin W.L., Tam M.F., Chou H., Wang C.W., Tsai J.J., Wang S.R., Han S.H. Identification of vacuolar serine proteinase as a major allergen of Aspergillus fumigatus by immunoblotting and N-terminal amino acid sequence analysis. Clin. Exp. Allergy. 2001;31:295–302. doi: 10.1046/j.1365-2222.2001.01026.x. [DOI] [PubMed] [Google Scholar]
  • 85.Lai H.Y., Tam M.F., Tang R.B., Chou H., Chang C.Y., Tsai J.J., Shen H.D. cDNA cloning and immunological characterization of a newly identified enolase allergen from Penicillium citrinum and Aspergillus fumigatus. Int. Arch. Allergy Immunol. 2002;127:181–190. doi: 10.1159/000053862. [DOI] [PubMed] [Google Scholar]
  • 86.Glaser A.G., Limacher A., Flückiger S., Scheynius A., Scapozza L., Crameri R. Analysis of the cross-reactivity and of the 1.5 A crystal structure of the Malassezia sympodialis Mala s 6 allergen, a member of the cyclophilin pan-allergen family. Biochem. J. 2006;396:41–49. doi: 10.1042/BJ20051708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Glaser A.G., Kirsch A.I., Zeller S., Menz G., Rhyner C., Crameri R. Molecular and immunological characterization of Asp f 34, a novel major cell wall allergen of Aspergillus fumigatus. Allergy. 2009;64:1144–1151. doi: 10.1111/j.1398-9995.2009.02029.x. [DOI] [PubMed] [Google Scholar]
  • 88.Rick E.M., Woolnough K., Richardson M., Monteiro W., Craner M., Bourne M., Cousins D.J., Swoboda I., Wardlaw A.J., Pashley C.H. Identification of allergens from Aspergillus fumigatus: Potential association with lung damage in asthma. Allergy. 2024;79:1208–1218. doi: 10.1111/all.16032. [DOI] [PubMed] [Google Scholar]
  • 89.Sander I., Raulf-Heimsoth M., Siethoff C., Lohaus C., Meyer H.E., Baur X. Allergy to Aspergillus-derived enzymes in the baking industry: Identification of beta-xylosidase from Aspergillus niger as a new allergen (Asp n 14) J. Allergy Clin. Immunol. 1998;102:256–264. doi: 10.1016/s0091-6749(98)70109-5. [DOI] [PubMed] [Google Scholar]
  • 90.Shen H.D., Lin W.L., Tam M.F., Wang S.R., Tsai J.J., Chou H., Han S.H. Alkaline serine proteinase: A major allergen of Aspergillus oryzae and its cross-reactivity with Penicillium citrinum. Int. Arch. Allergy Immunol. 1998;116:29–35. doi: 10.1159/000023921. [DOI] [PubMed] [Google Scholar]
  • 91.Shi C., Miller J.D. Characterization of the 41 kDa allergen Asp v 13, a subtilisin-like serine protease from Aspergillus versicolor. Mol. Immunol. 2011;48:1827–1834. doi: 10.1016/j.molimm.2011.05.010. [DOI] [PubMed] [Google Scholar]
  • 92.Krom B.P., Kidwai S., Ten Cate J.M. Candida and other fungal species: Forgotten players of healthy oral microbiota. J. Dent. Res. 2014;93:445–451. doi: 10.1177/0022034514521814. [DOI] [PubMed] [Google Scholar]
  • 93.Yadav A.N., Verma P., Kumar V., Sangwan P., Mishra S., Panjiar N., Gupta V.K., Saxena A.K. New and Future Developments in Microbial Biotechnology and Bioengineering. Elsevier; Amsterdam, The Netherlands: 2018. Biodiversity of the genus Penicillium in different habitats; pp. 3–18. [DOI] [Google Scholar]
  • 94.Shen H.D., Tam M.F., Tang R.B., Chou H. Aspergillus and Penicillium allergens: Focus on proteases. Curr. Allergy Asthma Rep. 2007;7:351–356. doi: 10.1007/s11882-007-0053-8. [DOI] [PubMed] [Google Scholar]
  • 95.Shen H.D., Lin W.L., Tsai J.J., Liaw S.F., Han S.H. Allergenic components in three different species of Penicillium: Crossreactivity among major allergens. Clin. Exp. Allergy. 1996;26:444–451. doi: 10.1111/j.1365-2222.1996.tb00561.x. [DOI] [PubMed] [Google Scholar]
  • 96.Sevinc M.S., Kumar V., Abebe M., Casley W.L., Vijay H.M. Isolation and characterization of a cDNA clone encoding one IgE-binding fragment of Penicillium brevicompactum. Int. Arch. Allergy Immunol. 2005;138:12–20. doi: 10.1159/000087353. [DOI] [PubMed] [Google Scholar]
  • 97.Shen H.D., Lin W.L., Tam M.F., Wang S.R., Tzean S.S., Huang M.H., Han S.H. Characterization of allergens from Penicillium oxalicum and P. notatum by immunoblotting and N-terminal amino acid sequence analysis. Clin. Exp. Allergy. 1999;29:642–651. doi: 10.1046/j.1365-2222.1999.00509.x. [DOI] [PubMed] [Google Scholar]
  • 98.Tai H.Y., Tam M.F., Chou H., Peng H.J., Su S.N., Perng D.W., Shen H.D. Pen ch 13 allergen induces secretion of mediators and degradation of occludin protein of human lung epithelial cells. Allergy. 2006;61:382–388. doi: 10.1111/j.1398-9995.2005.00958.x. [DOI] [PubMed] [Google Scholar]
  • 99.Shen H.D., Wang C.W., Chou H., Lin W.L., Tam M.F., Huang M.H., Kuo M.L., Wang S.R., Han S.H. Complementary DNA cloning and immunologic characterization of a new Penicillium citrinum allergen (Pen c 3) J. Allergy Clin. Immunol. 2000;105:827–833. doi: 10.1067/mai.2000.105220. [DOI] [PubMed] [Google Scholar]
  • 100.Shen H.D., Au L.C., Lin W.L., Liaw S.F., Tsai J.J., Han S.H. Molecular cloning and expression of a Penicillium citrinum allergen with sequence homology and antigenic crossreactivity to a hsp 70 human heat shock protein. Clin. Exp. Allergy. 1997;27:682–690. doi: 10.1111/j.1365-2222.1997.tb01197.x. [DOI] [PubMed] [Google Scholar]
  • 101.Tang R.B., Chen Y.S., Chou H., Lee S.S., Tai H.Y., Shen H.D. cDNA cloning and immunologic characterization of a novel EF-1beta allergen from Penicillium citrinum. Allergy. 2005;60:366–371. doi: 10.1111/j.1398-9995.2005.00706.x. [DOI] [PubMed] [Google Scholar]
  • 102.Chiu L.L., Lee K.L., Lin Y.F., Chu C.Y., Su S.N., Chow L.P. Secretome analysis of novel IgE-binding proteins from Penicillium citrinum. Proteom. Clin. Appl. 2008;2:33–45. doi: 10.1002/prca.200780050. [DOI] [PubMed] [Google Scholar]
  • 103.Sevinc M.S., Kumar V., Abebe M., Lemieux M., Vijay H.M. Isolation, expression and characterization of a minor allergen from Penicillium crustosum. Med. Mycol. 2014;52:81–89. doi: 10.3109/13693786.2013.813086. [DOI] [PubMed] [Google Scholar]
  • 104.Shen H.D., Wang C.W., Lin W.L., Lai H.Y., Tam M.F., Chou H., Wang S.R., Han S.H. cDNA cloning and immunologic characterization of Pen o 18, the vacuolar serine protease major allergen of Penicillium oxalicum. J. Lab. Clin. Med. 2001;137:115–124. doi: 10.1067/mlc.2001.112096. [DOI] [PubMed] [Google Scholar]
  • 105.Flannigan B., Samson R.A., Miller J.D. Microorganisms in Home and Indoor Work Environments: Diversity, Health Impacts, Investigation and Control. CRC Press; Boca Raton, FL, USA: 2002. [Google Scholar]
  • 106.Rizzi-Longo L., Pizzulin-Sauli M., Ganis P. Seasonal occurrence of Alternaria [1993–2004] and Epicoccum [1994–2004] spores in Trieste [NE Italy] Ann. Agric. Environ. Med. 2009;16:63–70. [PubMed] [Google Scholar]
  • 107.Bisht V., Singh B.P., Arora N., Gaur S.N., Sridhara S. Antigenic and allergenic cross-reactivity of Epicoccum nigrum with other fungi. Ann. Allergy Asthma Immunol. 2002;89:285–291. doi: 10.1016/s1081-1206(10)61956-4. [DOI] [PubMed] [Google Scholar]
  • 108.Bisht V., Arora N., Singh B.P., Gaur S.N., Sridhara S. Purification and characterization of a major cross-reactive allergen from Epicoccum purpurascens. Int. Arch. Allergy Immunol. 2004;133:217–224. doi: 10.1159/000076827. [DOI] [PubMed] [Google Scholar]
  • 109.Schöniger S., Roschanski N., Rösler U., Vidovic A., Nowak M., Dietz O., Wittenbrink M.M., Schoon H.A. Prototheca species and Pithomyces chartarum as causative agents of rhinitis and/or sinusitis in horses. J. Comp. Pathol. 2016;155:121–125. doi: 10.1016/j.jcpa.2016.06.004. [DOI] [PubMed] [Google Scholar]
  • 110.Kruczek A. Mycological analysis of air in selected rooms of the University of Szczecin—A pilot project. Acta Agrobot. 2014;67:51–56. [Google Scholar]
  • 111.Ianovici N. Atmospheric concentrations of selected allergenic fungal spores in relation to some meteorological factors, in Timişoara (Romania) Aerobiologia. 2016;32:139–156. doi: 10.1007/s10453-016-9427-5. [DOI] [Google Scholar]
  • 112.Sercombe J.K., Green B.J., Tovey E.R. Novel technique allows simultaneous recognition of many genera of environmental fungi and conidia as allergen sources. J. Allergy Clin. Immunol. 2005;115:98. doi: 10.1016/j.jaci.2004.12.405. [DOI] [Google Scholar]
  • 113.Su H.Y., Hyde K.D., Maharachchikumbura S.S.N., Ariyawansa H.A., Luo Z.L., Promputtha I., Tian Q., Lin C.G., Shang Q.J., Zhao Y.C., et al. The families Distoseptisporaceae fam. nov., Kirschsteiniotheliaceae, Sporormiaceae and Torulaceae, with new species from freshwater in Yunnan Province, China. Fungal Divers. 2016;80:375–409. doi: 10.1007/s13225-016-0362-0. [DOI] [Google Scholar]
  • 114.Tian W., Su P., Chen Y., Maharachchikumbura S.S.N. Four new species of Torula (Torulaceae, Pleosporales) from Sichuan, China. J. Fungi. 2023;9:150. doi: 10.3390/jof9020150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 115.Saghir S.A., Bancroft J., Ansari R. Molds and mycotoxins indoors II: Toxicological perspective. Arch. Clin. Toxicol. 2025;7:8–40. doi: 10.46439/toxicology.7.033. [DOI] [Google Scholar]
  • 116.Wirth F., Goldani L.Z. Epidemiology of Rhodotorula: An emerging pathogen. Interdiscip. Perspect. Infect. Dis. 2012;2012:465717. doi: 10.1155/2012/465717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 117.Ioannou P., Vamvoukaki R., Samonis G. Rhodotorula species infections in humans: A systematic review. Mycoses. 2019;62:90–100. doi: 10.1111/myc.12856. [DOI] [PubMed] [Google Scholar]
  • 118.Chang C.Y., Chou H., Tam M.F., Tang R.B., Lai H.Y., Shen H.D. Characterization of enolase allergen from Rhodotorula mucilaginosa. J. Biomed. Sci. 2002;9:645–655. doi: 10.1159/000067279. [DOI] [PubMed] [Google Scholar]
  • 119.Chou H., Tam M.F., Lee S.S., Tai H.Y., Chang C.Y., Chou C.T., Shen H.D. A vacuolar serine protease (Rho m 2) is a major allergen of Rhodotorula mucilaginosa and belongs to a class of highly conserved pan-fungal allergens. Int. Arch. Allergy Immunol. 2005;138:134–141. doi: 10.1159/000088435. [DOI] [PubMed] [Google Scholar]
  • 120.Pogner C., Gorfer M., Raulf M., Strauss J., Sander I. Quantification of airborne fungal antigens by ELISA and comparison to molecular biological and classical methods. Appl. Environ. Microbiol. 2025;91:e00163-25. doi: 10.1128/aem.00163-25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 121.Levetin E. Methods for aeroallergen sampling. Curr. Allergy Asthma Rep. 2004;4:376–383. doi: 10.1007/s11882-004-0088-z. [DOI] [PubMed] [Google Scholar]
  • 122.Levetin E., McLoud J.D., Pityn P. Air sampling and analysis of aeroallergens: Current and future approaches. Curr. Allergy Asthma Rep. 2023;23:223–236. doi: 10.1007/s11882-023-01073-2. [DOI] [PubMed] [Google Scholar]
  • 123.Nelson H.S., Solomon W.R. How ill the wind? Issues in aeroallergen sampling. J. Allergy Clin. Immunol. 2003;112:3–9. doi: 10.1067/mai.2003.1599. [DOI] [PubMed] [Google Scholar]
  • 124.Martinez-Bracero M., Markey E., Clancy J.H., McGillicuddy E.J., Sewell G., O’Connor D.J. Airborne fungal spore review, new advances and automatisation. Atmosphere. 2022;13:308. doi: 10.3390/atmos13020308. [DOI] [Google Scholar]
  • 125.Adamov S., Lemonis N., Clot B. On the measurement uncertainty of Hirst-type volumetric pollen and spore samplers. Aerobiologia. 2024;40:77–91. doi: 10.1007/s10453-021-09724-5. [DOI] [Google Scholar]
  • 126.Morris G., Kokki M.H., Anderson K., Richardson M.D. Sampling of Aspergillus spores in air. J. Hosp. Infect. 2000;44:81–92. doi: 10.1053/jhin.1999.0688. [DOI] [PubMed] [Google Scholar]
  • 127.Cox J., Mbareche H., Lindsley W.G., Duchaine C. Field sampling of indoor bioaerosols. Aerosol Sci. Technol. 2020;54:572–584. doi: 10.1080/02786826.2019.1688759. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 128.Aydin S. A short history, principles, and types of ELISA, and our laboratory experience with peptide/protein analyses using ELISA. Peptides. 2015;72:4–15. doi: 10.1016/j.peptides.2015.04.012. [DOI] [PubMed] [Google Scholar]
  • 129.Vailes L., Sridhara S., Cromwell O., Weber B., Breitenbach M., Chapman M. Quantitation of the major fungal allergens, Alt a 1 and Asp f 1, in commercial allergenic products. J. Allergy Clin. Immunol. 2001;107:641–646. doi: 10.1067/mai.2001.114118. [DOI] [PubMed] [Google Scholar]
  • 130.Sander I., Zahradnik E., van Kampen V., Kespohl S., Stubel H., Fischer G., Brüning T., Bünger J., Raulf-Heimsoth M. Development and application of mold antigen-specific enzyme-linked immunosorbent assays (ELISA) to quantify airborne antigen exposure. J. Toxicol. Environ. Health A. 2012;75:1185–1193. doi: 10.1080/15287394.2012.707603. [DOI] [PubMed] [Google Scholar]
  • 131.Chapman M.D., Tsay A., Vailes L.D. Home allergen monitoring and control—Improving clinical practice and patient benefits. Allergy. 2001;56:604–610. doi: 10.1034/j.1398-9995.2001.00049.x. [DOI] [PubMed] [Google Scholar]
  • 132.Baker M.J., Trevisan J., Bassan P., Bhargava R., Butler H.J., Dorling K.M., Fielden P.R., Fogarty S.W., Fullwood N.J., Heys K.A., et al. Using Fourier transform IR spectroscopy to analyze biological materials. Nat. Protoc. 2014;9:1771–1791. doi: 10.1038/nprot.2014.110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 133.Zimmermann B., Tkalčec Z., Mešić A., Kohler A. Characterizing aeroallergens by infrared spectroscopy of fungal spores and pollen. PLoS ONE. 2015;10:e0124240. doi: 10.1371/journal.pone.0124240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 134.Green B.J., Tovey E.R., Beezhold D.H., Perzanowski M.S., Acosta L.M., Divjan A.I., Chew G.L. Surveillance of fungal allergic sensitization using the fluorescent halogen immunoassay. J. Mycol. Med. 2009;19:253–261. doi: 10.1016/j.mycmed.2009.10.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 135.Memon R., Niazi J.H., Qureshi A. Biosensors for detection of airborne pathogenic fungal spores: A review. Nanoscale. 2024;16:15419–15445. doi: 10.1039/d4nr01175a. [DOI] [PubMed] [Google Scholar]
  • 136.Mousavian Z., Fahimi-Kashani E., Nafisi V., Fahimi-Kashani N. Recent advances in development of biosensors for monitoring of airborne microorganisms. Iran. J. Biotechnol. 2024;22:e3722. doi: 10.30498/ijb.2024.399314.3722. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 137.Jutel M., Agache I., Bonini S., Burks A.W., Calderon M., Canonica W., Cox L., Demoly P., Frew A.J., O’Hehir R., et al. International consensus on allergy immunotherapy. J. Allergy Clin. Immunol. 2015;136:556–568. doi: 10.1016/j.jaci.2015.04.047. [DOI] [PubMed] [Google Scholar]
  • 138.Singh A.B., Mathur C. Allergen preparation and standardization: An overview. In: Prasad R., editor. Clinical Allergy. 2nd ed. JP Medical Ltd.; London, UK: 2019. pp. 76–81. Chapter 8. [Google Scholar]
  • 139.Zimmer J., Bridgewater J., Ferreira F., Ree R., Rabin R.L., Vieths S. The history, present and future of allergen standardization in the United States and Europe. Front. Immunol. 2021;12:725831. doi: 10.3389/fimmu.2021.725831. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 140.Zimmer J., Vieths S., Kaul S. Standardization and regulation of allergen products in the European Union. Curr. Allergy Asthma Rep. 2016;16:21. doi: 10.1007/s11882-016-0599-4. [DOI] [PubMed] [Google Scholar]
  • 141.Jutel M., Agache I., Bonini S., Burks A.W., Calderon M., Canonica W., Cox L., Demoly P., Frew A.J., O’Hehir R., et al. International consensus on allergen immunotherapy II: Mechanisms, standardization, and pharmacoeconomics. J. Allergy Clin. Immunol. 2016;137:358–368. doi: 10.1016/j.jaci.2015.12.1300. [DOI] [PubMed] [Google Scholar]
  • 142.Ianovici N., Maria C., Răduțoiu M.N., Haniș A., Tudorică D. Variation in airborne fungal spore concentrations in four different microclimate regions in Romania. Not. Bot. Horti Agrobot. Cluj-Napoca. 2013;41:450. doi: 10.15835/nbha4129032. [DOI] [Google Scholar]
  • 143.Damialis A., Kaimakamis E., Konoglou M., Akritidis I., Traidl-Hoffmann C., Gioulekas D. Estimating the abundance of airborne pollen and fungal spores at variable elevations using an aircraft: How high can they fly? Sci. Rep. 2017;7:44535. doi: 10.1038/srep44535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 144.Grinn-Gofroń A., Bosiacka B. Effects of meteorological factors on the composition of selected fungal spores in the air. Aerobiologia. 2015;31:63–72. doi: 10.1007/s10453-014-9347-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 145.Oliveira M., Ribeiro H., Abreu I. Annual variation of fungal spores in atmosphere of Porto: 2003. Ann. Agric. Environ. Med. 2005;12:309–315. [PubMed] [Google Scholar]
  • 146.Sabariego S., Guardia C., Alba F. The effect of meteorological factors on the daily variation of airborne fungal spores in Granada (southern Spain) Int. J. Biometeorol. 2000;44:1–5. doi: 10.1007/s004840050131. [DOI] [PubMed] [Google Scholar]
  • 147.Ščevková J., Kováč J. First fungal spore calendar for the atmosphere of Bratislava, Slovakia. Aerobiologia. 2019;35:343–356. doi: 10.1007/s10453-019-09564-4. [DOI] [Google Scholar]
  • 148.Sarda-Estève R., Baisnée D., Guinot B., Sodeau J., O’Connor D., Belmonte J., Besancenot J.-P., Petit J.-E., Thibaudon M., Oliver G., et al. Variability and geographical origin of five years airborne fungal spore concentrations measured at Saclay, France from 2014 to 2018. Remote Sens. 2019;11:1671. doi: 10.3390/rs11141671. [DOI] [Google Scholar]
  • 149.Lim S.H., Chew F.T., Binti Mohd Dali S.D., Wah Tan H.T., Lee B.W., Tan T.K. Outdoor airborne fungal spores in Singapore. Grana. 1998;37:246–252. doi: 10.1080/00173139809362674. [DOI] [Google Scholar]
  • 150.Kumar A., Attri A.K. Characterization of fungal spores in ambient particulate matter: A study from the Himalayan region. Atmos. Environ. 2016;142:182–193. doi: 10.1016/j.atmosenv.2016.07.049. [DOI] [Google Scholar]
  • 151.Khan Z., Khan M., Chandy R., Sharma P. Aspergillus and other molds in the air of Kuwait. Mycopathologia. 1999;146:25–32. doi: 10.1023/a:1007034703398. [DOI] [PubMed] [Google Scholar]
  • 152.Yang L., Li W., Qi S., Jiang Q., Huang N., Yang Y., Ma D., Zhang W., Chen H., Zhu R. A survey of airborne fungi and their sensitization profile in Wuhan, China. Int. Arch. Allergy Immunol. 2023;184:1153–1164. doi: 10.1159/000531245. [DOI] [PubMed] [Google Scholar]
  • 153.Kwong K., Robinson M., Sullivan A., Letovsky S., Liu A.H., Valcour A. Fungal allergen sensitization: Prevalence, risk factors, and geographic variation in the United States. J. Allergy Clin. Immunol. 2023;152:1658–1668. doi: 10.1016/j.jaci.2023.09.010. [DOI] [PubMed] [Google Scholar]
  • 154.Almaguer M., Aira M.J., Rodríguez-Rajo F.J., Fernandez-Gonzalez M., Rojas-Flores T.I. Thirty-four identifiable airborne fungal spores in Havana, Cuba. Ann. Agric. Environ. Med. 2015;22:215–220. doi: 10.5604/12321966.1152068. [DOI] [PubMed] [Google Scholar]
  • 155.Mallo A.C., Nitiu D.S., Gardella Sambeth M.C. Airborne fungal spore content in the atmosphere of the city of La Plata, Argentina. Aerobiologia. 2011;27:77–84. doi: 10.1007/s10453-010-9172-0. [DOI] [Google Scholar]
  • 156.Gonçalves V.N., Oliveira F.S., Carvalho C.R. Antarctic rocks from continental Antarctica as source of potential human opportunistic fungi. Extremophiles. 2017;21:851–860. doi: 10.1007/s00792-017-0947-x. [DOI] [PubMed] [Google Scholar]
  • 157.Menezes G.C.A., Câmara P.E.A.S., Pinto O.H.B. Fungi in the Antarctic cryosphere: Using DNA metabarcoding to reveal fungal diversity in glacial ice from the Antarctic Peninsula region. Microb. Ecol. 2022;83:647–657. doi: 10.1007/s00248-021-01792-x. [DOI] [PubMed] [Google Scholar]
  • 158.Ajikah L.B., Roffe S.J., Neumann F.H. Meteorological influences on airborne pollen and spores in Johannesburg (Gauteng), South Africa. Aerobiologia. 2023;39:363–388. doi: 10.1007/s10453-023-09799-2. [DOI] [Google Scholar]
  • 159.Ndjindji O.M., Rogombe S.M.O., Bissiengou P.M., Mveang-Nzoghe A., Leboueny M., Mbina O., Maloupazoa Siawaya A.C., KuissiKamgaing E., Ndeboko B., Ategbo S., et al. Allergen sensitization and polysensitization pattern of adults and children in an urban Sub-Saharan African setting (Libreville, Gabon) J. Allergy Clin. Immunol. Glob. 2023;2:23–29. doi: 10.1016/j.jacig.2022.10.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 160.Mitakakis T.Z., Tovey E.R., Xuan W., Marks G.B. Personal exposure to allergenic pollen and mould spores in inland New South Wales, Australia. Clin. Exp. Allergy. 2000;30:1733–1739. doi: 10.1046/j.1365-2222.2000.00966.x. [DOI] [PubMed] [Google Scholar]
  • 161.Matheson M.C., Reece J.C., Kandane-Rathnayake R.K., Tang M.L.K., Simpson J.A., Feather I.H., Southey M.C., Tsimiklis H., Hopper J.L., Morrison S.C., et al. Mould-sensitized adults have lower Th2 cytokines and a higher prevalence of asthma than those sensitized to other aeroallergens. Allergy. 2016;71:1701–1711. doi: 10.1111/all.12964. [DOI] [PubMed] [Google Scholar]
  • 162.Xu J. Assessing global fungal threats to humans. mLife. 2022;1:223–240. doi: 10.1002/mlf2.12036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 163.Hughes K.M., Price D., Torriero A.A.J., Symonds M.R.E., Suphioglu C. Impact of fungal spores on asthma prevalence and hospitalization. Int. J. Mol. Sci. 2022;23:4313. doi: 10.3390/ijms23084313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 164.Vitte J., Michel M., Malinovschi A., Caminati M., Odebode A., Annesi-Maesano I., Caimmi D.P., Cassagne C., Demoly P., Heffler E., et al. Fungal exposome, human health, and unmet needs: A 2022 update with special focus on allergy. Allergy. 2022;77:3199–3216. doi: 10.1111/all.15483. [DOI] [PubMed] [Google Scholar]
  • 165.Barnes C.S., Khurana Hershey G.K. Indoor and outdoor fungal allergens and impacts on respiratory allergic disease. J. Allergy Clin. Immunol. Pract. 2025;13:1267–1271. doi: 10.1016/j.jaip.2025.03.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 166.Ziaei S., Sarkhosh M., Saeidi M., Sarkhoshkalat M. Public health implications of bacterial and fungal bioaerosol concentrations in outdoor air. Sci. Rep. 2025;15:22706. doi: 10.1038/s41598-025-08196-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 167.Alam S., Nisar M., Bano S.A., Ahmad T. Impact of aerial fungal spores on human health. In: Ahmed T., Hashmi M.Z., editors. Hazardous Environmental Micro-Pollutants, Health Impacts and Allied Treatment Technologies. Springer International Publishing; Cham, Switzerland: 2022. pp. 219–240. [DOI] [Google Scholar]
  • 168.Baxi S.N., Portnoy J.M., Larenas-Linnemann D., Phipatanakul W. on behalf of the Environmental Allergens Workgroup. Exposure and health effects of fungi on humans. J. Allergy Clin. Immunol. Pract. 2016;4:396–404. doi: 10.1016/j.jaip.2016.01.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 169.Shelton B.G., Kirkland K.H., Flanders W.D., Morris G.K. Profiles of airborne fungi in buildings and outdoor environments in the United States. Appl. Environ. Microbiol. 2002;68:1743–1753. doi: 10.1128/AEM.68.4.1743-1753.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 170.Do Nascimento J.P.M., Queijeiro López A.M., De Araújo M.A., De Araujo L.A., Silva Filho E.A.D. Airborne fungi in indoor hospital environments. Int. J. Curr. Microbiol. Appl. Sci. 2019;8:2749–2772. doi: 10.20546/ijcmas.2019.801.291. [DOI] [Google Scholar]
  • 171.Caillaud D., Leynaert B., Keirsbulck M., Nadif R. Indoor mould exposure, asthma and rhinitis: Findings from systematic reviews and recent longitudinal studies. Eur. Respir. Rev. 2018;27:170137. doi: 10.1183/16000617.0137-2017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 172.Kour D., Khan S.S., Gusain M., Bassi A., Kaur T., Kataria A., Kaur S., Kour H. Airborne fungal communities: Diversity, health impacts, and potential AI applications in aeromycology. Aerobiology. 2025;3:10. doi: 10.3390/aerobiology3040010. [DOI] [Google Scholar]
  • 173.Gabriel M.F., Postigo I., Tomaz C.T., Martínez J. Alternaria alternata allergens: Markers of exposure, phylogeny and risk of fungi-induced respiratory allergy. Environ. Int. 2016;90:71–80. doi: 10.1016/j.envint.2016.01.003. [DOI] [PubMed] [Google Scholar]
  • 174.Abbas S., Katelaris C.H., Singh A.B., Raza S.M., Ajab Khan M., Rashid M., Abbas M., Ismail M. World Allergy Organization study on aerobiology for creating first pollen and mold calendar with clinical significance in Islamabad, Pakistan; a project of World Allergy Organization and Pakistan Allergy, Asthma & Clinical Immunology Centre of Islamabad. World Allergy Organ. J. 2012;5:103–111. doi: 10.1097/wox.0b013e31826421c8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 175.Kasprzyk I., Grinn-Gofroń A., Ćwik A., Kluska K., Cariñanos P., Wójcik T. Allergenic fungal spores in the air of urban parks. Aerobiologia. 2021;37:39–51. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The original contributions presented in this study are included in the article. Further inquiries can be directed to the corresponding author.


Articles from Medicina are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES